Abstract – OVERALL COMPONENT
The goal of this application is the continued development and maintenance of the Gene Expression
Database for Mouse Development (GXD). GXD is a well-established community resource. It integrates
different types of expression data including biologically complex data, such as RNA in situ hybridization and
immunohistochemistry results, and high-throughput expression data from RNA-seq experiments. It places
these data in the larger biological context through integration with other Mouse Genome Informatics (MGI)
resources and interconnections with many other databases, supporting complex queries that enable thorough
biological and computational analyses.
The specific aims of this proposal are (1) to continue and expand GXD’s curation of expression data and
anatomical ontologies and ensure high-quality data annotation and integration. We will continue to
curate data from RNA in situ hybridization, in situ-reporter knock-in, immunohistochemistry, RT-PCR, Northern
blot and Western blot experiments; and expand our annotation of bulk and single-cell RNA-seq data sets. We
will enhance the mouse anatomy ontology, and refine our expression annotations by combining anatomy and
cell type terms. We will (2) maintain the GXD database and enhance GXD’s infrastructure and data entry
interfaces to accommodate large volumes of expression data and to represent new types of data and
relationships. We will enhance the database and software infrastructure to accommodate the expected
increase in RNA-seq data. We will expand the database to represent anatomical differentiation pathways, as
well as expression annotations to cell type terms. We will continue to modernize the editorial interface and
expand the interface as needed for the annotation of new data types. We will automate more steps of the
literature selection process to increase curation efficiency. We will (3) continue to evolve GXD’s user
interface and develop advanced query and display tools. We will develop expression searches that allow
the analysis of anatomical differentiation pathways and cell types. We will add support for quantitative
expression analyses, comparisons and profiling. We will develop displays that superimpose expression data
with molecular pathway and protein interaction data to support the analysis of molecular networks with co-
expression information. We will (4) provide user support and promote use of GXD by the scientific
community. We will continue to provide training and to solicit feedback on how we can improve GXD.
Public Health Relevance Statement
Project Narrative/Relevance to Public Health
The Gene Expression Database for Mouse Development (GXD) allows the scientific community to examine
patterns of gene expression, elucidate biologically important molecular networks, and explore the genetic
programs that underlie normal development and disregulations of development leading to human birth defects,
to cancer and to many other diseases.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
042140483
UEI
XR6LMXNKDJJ1
Project Start Date
02-December-2010
Project End Date
30-April-2026
Budget Start Date
01-May-2022
Budget End Date
30-April-2023
Project Funding Information for 2022
Total Funding
$2,146,600
Direct Costs
$1,262,706
Indirect Costs
$883,894
Year
Funding IC
FY Total Cost by IC
2022
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$2,146,600
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P41HD062499-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41HD062499-12
Patents
No Patents information available for 5P41HD062499-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41HD062499-12
Clinical Studies
No Clinical Studies information available for 5P41HD062499-12
News and More
Related News Releases
No news release information available for 5P41HD062499-12
History
No Historical information available for 5P41HD062499-12
Similar Projects
No Similar Projects information available for 5P41HD062499-12